Olinger, Jonathan
`
`From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Parezo, Jessica <jparezo@cov.com>
`Friday, August 04, 2017 4:22 PM
`Olinger, Jonathan; Holloway, Clay; Mylan-WC-IPR; Stockwell, Mitch
`Reister, Andrea; Kamholz, Scott; MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch,
`LLP (maa@bskb.com); Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP
`(Lynde.Herzbach@bskb.com)
`RE: IPR2017-00203: Dr. McConville's Deposition
`
`Jonathan,
`
`We decline to produce Mr. Tanjoh for cross-examination in the IPR proceeding. Instead, however, Patent Owner would
`consent to using the March 2017 deposition transcript from the litigation in the IPR proceeding, and would work with
`Petitioner to file the appropriate protective order papers, if necessary, in the district court and the IPR proceeding.
`
`In the event Petitioner chooses to proceed with a motion for additional discovery in the IPR proceeding, Patent Owner
`will provide its arguments in the opposition paper.
`
`Regards,
`Jessica
`
`
`Jessica Parezo
`
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001-4956
`T +1 202 662 5498 | jparezo@cov.com
`www.cov.com
`
`
`
`
`This message is from a law firm and may contain information that is confidential or legally privileged. If you are not the intended recipient, please
`immediately advise the sender by reply e-mail that this message has been inadvertently transmitted to you and delete this e-mail from your system.
`Thank you for your cooperation.
`
`
`
`
`From: Olinger, Jonathan [mailto:JOlinger@kilpatricktownsend.com]
`Sent: Thursday, August 03, 2017 5:20 PM
`To: Parezo, Jessica <jparezo@cov.com>; Holloway, Clay <CHolloway@kilpatricktownsend.com>; Mylan-WC-IPR <Mylan-
`WC-IPR@kilpatricktownsend.com>; Stockwell, Mitch <MStockwell@kilpatricktownsend.com>
`Cc: Reister, Andrea <areister@cov.com>; Kamholz, Scott <SKamholz@cov.com>; MaryAnne Armstrong - Birch, Stewart,
`Kolasch & Birch, LLP (maa@bskb.com) <maa@bskb.com>; Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP
`(Lynde.Herzbach@bskb.com) <Lynde.Herzbach@bskb.com>
`Subject: RE: IPR2017-00203: Dr. McConville's Deposition
`
`Jessica,
`
`
`Following up on the Board’s response to our request for a teleconference, please confirm by Monday, August 7th
`whether Patent Owner will agree to make its declarant, Mr. Tanjoh, available for cross-examination. If Patent Owner
`
`1
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1022 - Page 1
`
`

`

`continues to refuse to make Mr. Tanjoh available, please provide an explanation as to the basis for Patent Owner’s
`refusal. We request more than a simple statement that you disagree with our analysis.
`
`
`Best regards,
`Jonathan
`
`
`Jonathan D. Olinger
`Kilpatrick Townsend & Stockton LLP
`Suite 2800 | 1100 Peachtree Street NE | Atlanta, GA 30309-4528
`office 404 745 2426 | fax 404 541 3326
`jolinger@kilpatricktownsend.com | My Profile | vCard
`
`From: Parezo, Jessica [mailto:jparezo@cov.com]
`Sent: Thursday, August 03, 2017 2:34 PM
`To: Holloway, Clay; Olinger, Jonathan; Mylan-WC-IPR; Stockwell, Mitch
`Cc: Reister, Andrea; Kamholz, Scott; MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch, LLP (maa@bskb.com);
`Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP (Lynde.Herzbach@bskb.com)
`Subject: RE: IPR2017-00203: Dr. McConville's Deposition
`
`Clay,
`Yes, we are available tomorrow morning. We are also available in the afternoon, if that is more convenient for the
`Board. If any of those times are acceptable, please proceed to coordinate with the Board.
`
`We are not available on Tuesday, August 8. We can provide availability for later in the week if necessary.
`
`Regards,
`Jessica
`
`
`
`Jessica Parezo
`
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001-4956
`T +1 202 662 5498 | jparezo@cov.com
`www.cov.com
`
`
`
`
`This message is from a law firm and may contain information that is confidential or legally privileged. If you are not the intended recipient, please
`immediately advise the sender by reply e-mail that this message has been inadvertently transmitted to you and delete this e-mail from your system.
`Thank you for your cooperation.
`
`
`
`
`From: Holloway, Clay [mailto:CHolloway@kilpatricktownsend.com]
`Sent: Thursday, August 03, 2017 1:02 PM
`To: Parezo, Jessica <jparezo@cov.com>; Olinger, Jonathan <JOlinger@kilpatricktownsend.com>; Mylan-WC-IPR <Mylan-
`WC-IPR@kilpatricktownsend.com>; Stockwell, Mitch <MStockwell@kilpatricktownsend.com>
`Cc: Reister, Andrea <areister@cov.com>; Kamholz, Scott <SKamholz@cov.com>; MaryAnne Armstrong - Birch, Stewart,
`Kolasch & Birch, LLP (maa@bskb.com) <maa@bskb.com>; Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP
`(Lynde.Herzbach@bskb.com) <Lynde.Herzbach@bskb.com>
`Subject: RE: IPR2017-00203: Dr. McConville's Deposition
`
`
`2
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1022 - Page 2
`
`

`

`I received a voicemail about having the call tomorrow. Could we do before noon?
`
`Clay Holloway
`Kilpatrick Townsend & Stockton LLP
`Suite 2800 | 1100 Peachtree Street NE | Atlanta, GA 30309-4528
`office 404 815 6537 | fax 404 541 3484
`cholloway@kilpatricktownsend.com | My Profile | vCard
`
`From: Holloway, Clay
`Sent: Thursday, August 03, 2017 10:08 AM
`To: 'Parezo, Jessica'; Olinger, Jonathan; Mylan-WC-IPR; Stockwell, Mitch
`Cc: Reister, Andrea; Kamholz, Scott; MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch, LLP (maa@bskb.com);
`Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP (Lynde.Herzbach@bskb.com)
`Subject: RE: IPR2017-00203: Dr. McConville's Deposition
`
`Jessica,
`
`We are disappointed to hear Qualicaps’ position on this matter. Petitioner will seek the testimony of Tanjoh-san as
`routine discovery, or in the alternative, seek leave of the Board to file a motion for additional discovery in the form of
`Tanjoh-san’s deposition.
`
`Please provide your availability for a call with the Board on Tuesday August 8.
`
`Best regards,
`Clay
`
`
`Clay Holloway
`Kilpatrick Townsend & Stockton LLP
`Suite 2800 | 1100 Peachtree Street NE | Atlanta, GA 30309-4528
`office 404 815 6537 | fax 404 541 3484
`cholloway@kilpatricktownsend.com | My Profile | vCard
`
`From: Parezo, Jessica [mailto:jparezo@cov.com]
`Sent: Monday, July 31, 2017 10:08 AM
`To: Holloway, Clay; Olinger, Jonathan; Mylan-WC-IPR; Stockwell, Mitch
`Cc: Reister, Andrea; Kamholz, Scott; MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch, LLP (maa@bskb.com);
`Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP (Lynde.Herzbach@bskb.com)
`Subject: RE: IPR2017-00203: Dr. McConville's Deposition
`
`Clay,
`
`
`We do not agree with your analysis, and, as such, do not agree to make Mr. Tanjoh available for cross-examination in
`this proceeding.
`
`Regards,
`Jessica
`
`
`Jessica Parezo
`
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001-4956
`T +1 202 662 5498 | jparezo@cov.com
`www.cov.com
`
`3
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1022 - Page 3
`
`

`

`
`
`
`
`This message is from a law firm and may contain information that is confidential or legally privileged. If you are not the intended recipient, please
`immediately advise the sender by reply e-mail that this message has been inadvertently transmitted to you and delete this e-mail from your system.
`Thank you for your cooperation.
`
`
`
`From: Holloway, Clay [mailto:CHolloway@kilpatricktownsend.com]
`Sent: Thursday, July 27, 2017 10:51 AM
`To: Parezo, Jessica <jparezo@cov.com>; Olinger, Jonathan <JOlinger@kilpatricktownsend.com>; Mylan-WC-IPR <Mylan-
`WC-IPR@kilpatricktownsend.com>; Stockwell, Mitch <MStockwell@kilpatricktownsend.com>
`Cc: Reister, Andrea <areister@cov.com>; Kamholz, Scott <SKamholz@cov.com>; MaryAnne Armstrong - Birch, Stewart,
`Kolasch & Birch, LLP (maa@bskb.com) <maa@bskb.com>; Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP
`(Lynde.Herzbach@bskb.com) <Lynde.Herzbach@bskb.com>
`Subject: RE: IPR2017-00203: Dr. McConville's Deposition
`
`Jessica,
`Petitioner points you to 37 CFR 42.53 regarding submission of direct testimony. Petitioner further points you to 77 Fed.
`Reg. 48756, 48761 (Aug. 12, 2012) regarding any testimony submitted by affidavit or declaration should arrange to make
`the witness available for cross-examination. If it is Patent Owner’s intention to rely on the inventor declarations
`submitted in the prosecution of the patent, then Patent Owner needs to make the declarant available for deposition.
`As such, please let us know when Tanjoh-san’s is available for deposition in San Francisco as soon as possible.
`Regards,
`Clay
`
`Clay Holloway
`Kilpatrick Townsend & Stockton LLP
`Suite 2800 | 1100 Peachtree Street NE | Atlanta, GA 30309-4528
`office 404 815 6537 | fax 404 541 3484
`cholloway@kilpatricktownsend.com | My Profile | vCard
`
`From: Parezo, Jessica [mailto:jparezo@cov.com]
`Sent: Wednesday, July 26, 2017 3:45 PM
`To: Olinger, Jonathan; Mylan-WC-IPR; Stockwell, Mitch; Holloway, Clay
`Cc: Reister, Andrea; Kamholz, Scott; MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch, LLP (maa@bskb.com);
`Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP (Lynde.Herzbach@bskb.com)
`Subject: RE: IPR2017-00203: Dr. McConville's Deposition
`
`Jonathan,
`Patent Owner confirms Dr. McConville's deposition will take place on Thursday, August 17 at Covington's DC
`office.
`
`Your email does not provide a basis for Petitioner's request to depose Mr. Tanjoh. Please provide a basis in the
`patent trial rules to support the request.
`
`Regards,
`Jessica
`
`
`Jessica Parezo
`
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`
`4
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1022 - Page 4
`
`

`

`Washington, DC 20001-4956
`T +1 202 662 5498 | jparezo@cov.com
`www.cov.com
`
`
`
`
`This message is from a law firm and may contain information that is confidential or legally privileged. If you are not the intended recipient, please
`immediately advise the sender by reply e-mail that this message has been inadvertently transmitted to you and delete this e-mail from your system.
`Thank you for your cooperation.
`
`
`From: Olinger, Jonathan [mailto:JOlinger@kilpatricktownsend.com]
`Sent: Tuesday, July 25, 2017 3:32 PM
`To: Parezo, Jessica <jparezo@cov.com>; Mylan-WC-IPR <Mylan-WC-IPR@kilpatricktownsend.com>; Stockwell, Mitch
`<MStockwell@kilpatricktownsend.com>; Holloway, Clay <CHolloway@kilpatricktownsend.com>
`Cc: Reister, Andrea <areister@cov.com>; Kamholz, Scott <SKamholz@cov.com>; MaryAnne Armstrong - Birch, Stewart,
`Kolasch & Birch, LLP (maa@bskb.com) <maa@bskb.com>; Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP
`(Lynde.Herzbach@bskb.com) <Lynde.Herzbach@bskb.com>
`Subject: RE: IPR2017-00203: Dr. McConville's Deposition
`
`Counsel,
`
`My apologies. I meant August 17 for Dr. McConville’s deposition.
`
`Best,
`Jonathan
`
`Jonathan D. Olinger
`Kilpatrick Townsend & Stockton LLP
`Suite 2800 | 1100 Peachtree Street NE | Atlanta, GA 30309-4528
`office 404 745 2426 | fax 404 541 3326
`jolinger@kilpatricktownsend.com | My Profile | vCard
`
`From: Olinger, Jonathan
`Sent: Tuesday, July 25, 2017 3:28 PM
`To: 'Parezo, Jessica'; Mylan-WC-IPR; Stockwell, Mitch; Holloway, Clay
`Cc: Reister, Andrea; Kamholz, Scott; MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch, LLP (maa@bskb.com);
`Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP (Lynde.Herzbach@bskb.com)
`Subject: RE: IPR2017-00203: Dr. McConville's Deposition
`
`Counsel,
`
`Petitioner confirms that it will take Dr. McConville’s deposition on July 17th in Covington’s DC Office.
`
`Petitioner would also like to take the deposition of inventor Masaru Tanjoh in relation to this proceeding. No later than
`July 28, please provide us with Tanjoh-san’s availability for a deposition.
`
`Best regards,
`Jonathan
`
`
`Jonathan D. Olinger
`Kilpatrick Townsend & Stockton LLP
`Suite 2800 | 1100 Peachtree Street NE | Atlanta, GA 30309-4528
`office 404 745 2426 | fax 404 541 3326
`jolinger@kilpatricktownsend.com | My Profile | vCard
`
`5
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1022 - Page 5
`
`

`

`From: Parezo, Jessica [mailto:jparezo@cov.com]
`Sent: Friday, July 21, 2017 1:11 PM
`To: Mylan-WC-IPR; Stockwell, Mitch; Holloway, Clay; Olinger, Jonathan
`Cc: Reister, Andrea; Kamholz, Scott; MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch, LLP (maa@bskb.com);
`Lynde Herzbach - Birch, Stewart, Kolasch & Birch, LLP (Lynde.Herzbach@bskb.com)
`Subject: IPR2017-00203: Dr. McConville's Deposition
`
`Counsel:
`
`
`To facilitate scheduling during Petitioner's discovery period, we offer Dr. McConville's dates of availability for
`deposition at our DC office. The preferred deposition date is the 17th or 18th of August 2017. Alternatively,
`Dr. McConville can be available on August 3rd or 4th.
`
`Please let us know which of those dates would work.
`
`
`Regards,
`Jessica
`
`
`Jessica Parezo
`
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001-4956
`T +1 202 662 5498 | jparezo@cov.com
`www.cov.com
`
`
`
`
`This message is from a law firm and may contain information that is confidential or legally privileged. If you are not the intended recipient, please
`immediately advise the sender by reply e-mail that this message has been inadvertently transmitted to you and delete this e-mail from your system.
`Thank you for your cooperation.
`
`
`
`
`
`
`Confidentiality Notice:
`This communication constitutes an electronic communication within the meaning of the Electronic Communications Privacy Act, 18 U.S.C. Section 2510, and its
`disclosure is strictly limited to the recipient intended by the sender of this message. This transmission, and any attachments, may contain confidential attorney-
`client privileged information and attorney work product. If you are not the intended recipient, any disclosure, copying, distribution or use of any of the information
`contained in or attached to this transmission is STRICTLY PROHIBITED. Please contact us immediately by return e-mail or at 404 815 6500, and destroy the
`original transmission and its attachments without reading or saving in any manner.
`
`
`***DISCLAIMER*** Per Treasury Department Circular 230: Any U.S. federal tax advice contained in this communication (including any attachments) is not
`intended or written to be used, and cannot be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or
`recommending to another party any transaction or matter addressed herein.
`
`6
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1022 - Page 6
`
`